Email Print Share
October 24, 2014

An in-mouth wafer to treat oral cancer--biotech's future

To treat oral cancer, NSF-funded small business Privo Technologies has created a platform that delivers treatments directly to the affected area. Privo develops new classes of targeted treatments, such as chemotherapy drugs, designed to be delivered through the mouth's mucous membranes. Privo founder Manijeh Goldberg talked about her company's research at the 2014 BIO International Convention.

Credit: NSF


Images and other media in the National Science Foundation Multimedia Gallery are available for use in print and electronic material by NSF employees, members of the media, university staff, teachers and the general public. All media in the gallery are intended for personal, educational and nonprofit/non-commercial use only.

Videos credited to the National Science Foundation, an agency of the U.S. Government, may be distributed freely. However, some materials within the videos may be copyrighted. If you would like to use portions of NSF-produced programs in another product, please contact the Video Team in the Office of Legislative and Public Affairs at the National Science Foundation.

Additional information about general usage can be found in Conditions.